119 related articles for article (PubMed ID: 29669325)
1. Characterization of the σ-Pore in Mutant hKv1.3 Potassium Channels.
Tyutyaev P; Grissmer S
Cell Physiol Biochem; 2018; 46(3):1112-1121. PubMed ID: 29669325
[TBL] [Abstract][Full Text] [Related]
2. Observation of σ-pore currents in mutant hKv1.2_V370C potassium channels.
Tyutyaev P; Grissmer S
PLoS One; 2017; 12(4):e0176078. PubMed ID: 28426823
[TBL] [Abstract][Full Text] [Related]
3. Kinetic Aspects of Verapamil Binding (On-Rate) on Wild-Type and Six hKv1.3 Mutant Channels.
Diesch AK; Grissmer S
Cell Physiol Biochem; 2017; 44(1):172-184. PubMed ID: 29131061
[TBL] [Abstract][Full Text] [Related]
4. A novel current pathway parallel to the central pore in a mutant voltage-gated potassium channel.
Prütting S; Grissmer S
J Biol Chem; 2011 Jun; 286(22):20031-42. PubMed ID: 21498510
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
Jäger H; Grissmer S
Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028
[TBL] [Abstract][Full Text] [Related]
6. Mapping of maurotoxin binding sites on hKv1.2, hKv1.3, and hIKCa1 channels.
Visan V; Fajloun Z; Sabatier JM; Grissmer S
Mol Pharmacol; 2004 Nov; 66(5):1103-12. PubMed ID: 15286210
[TBL] [Abstract][Full Text] [Related]
7. Interaction of propofol with voltage-gated human Kv1.5 channel through specific amino acids within the pore region.
Kojima A; Ito Y; Ding WG; Kitagawa H; Matsuura H
Eur J Pharmacol; 2015 Oct; 764():622-632. PubMed ID: 26256861
[TBL] [Abstract][Full Text] [Related]
8. Charybdotoxin and margatoxin acting on the human voltage-gated potassium channel hKv1.3 and its H399N mutant: an experimental and computational comparison.
Nikouee A; Khabiri M; Grissmer S; Ettrich R
J Phys Chem B; 2012 May; 116(17):5132-40. PubMed ID: 22490327
[TBL] [Abstract][Full Text] [Related]
9. Interactions of Propofol With Human Voltage-gated Kv1.5 Channel Determined by Docking Simulation and Mutagenesis Analyses.
Kojima A; Fukushima Y; Ito Y; Ding WG; Ueda R; Seto T; Kitagawa H; Matsuura H
J Cardiovasc Pharmacol; 2018 Jan; 71(1):10-18. PubMed ID: 29283926
[TBL] [Abstract][Full Text] [Related]
10. Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels.
Bartok A; Toth A; Somodi S; Szanto TG; Hajdu P; Panyi G; Varga Z
Toxicon; 2014 Sep; 87():6-16. PubMed ID: 24878374
[TBL] [Abstract][Full Text] [Related]
11. The membrane permeable calcium chelator BAPTA-AM directly blocks human ether a-go-go-related gene potassium channels stably expressed in HEK 293 cells.
Tang Q; Jin MW; Xiang JZ; Dong MQ; Sun HY; Lau CP; Li GR
Biochem Pharmacol; 2007 Dec; 74(11):1596-607. PubMed ID: 17826747
[TBL] [Abstract][Full Text] [Related]
12. Regulation of a mammalian Shaker-related potassium channel, hKv1.5, by extracellular potassium and pH.
Jäger H; Grissmer S
FEBS Lett; 2001 Jan; 488(1-2):45-50. PubMed ID: 11163793
[TBL] [Abstract][Full Text] [Related]
13. Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from the venom of Tityus stigmurus.
Papp F; Batista CV; Varga Z; Herceg M; Román-González SA; Gaspar R; Possani LD; Panyi G
Toxicon; 2009 Sep; 54(4):379-89. PubMed ID: 19500613
[TBL] [Abstract][Full Text] [Related]
14. Structure, molecular modeling, and function of the novel potassium channel blocker urotoxin isolated from the venom of the Australian scorpion Urodacus yaschenkoi.
Luna-Ramírez K; Bartok A; Restano-Cassulini R; Quintero-Hernández V; Coronas FI; Christensen J; Wright CE; Panyi G; Possani LD
Mol Pharmacol; 2014 Jul; 86(1):28-41. PubMed ID: 24723491
[TBL] [Abstract][Full Text] [Related]
15. The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker.
Yang XF; Yang Y; Lian YT; Wang ZH; Li XW; Cheng LX; Liu JP; Wang YF; Gao X; Liao YH; Wang M; Zeng QT; Liu K
PLoS One; 2012; 7(4):e36379. PubMed ID: 22558454
[TBL] [Abstract][Full Text] [Related]
16. Molecular determinants of the inhibition of human Kv1.5 potassium currents by external protons and Zn(2+).
Kehl SJ; Eduljee C; Kwan DC; Zhang S; Fedida D
J Physiol; 2002 May; 541(Pt 1):9-24. PubMed ID: 12015417
[TBL] [Abstract][Full Text] [Related]
17. Identification of Verapamil Binding Sites Within Human Kv1.5 Channel Using Mutagenesis and Docking Simulation.
Ding WG; Tano A; Mi X; Kojima A; Seto T; Matsuura H
Cell Physiol Biochem; 2019; 52(2):302-314. PubMed ID: 30816676
[TBL] [Abstract][Full Text] [Related]
18. Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization.
Moreno I; Caballero R; González T; Arias C; Valenzuela C; Iriepa I; Gálvez E; Tamargo J; Delpón E
J Pharmacol Exp Ther; 2003 Feb; 304(2):862-73. PubMed ID: 12538844
[TBL] [Abstract][Full Text] [Related]
19. Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase.
Gong YZ; Ding WG; Wu J; Tsuji K; Horie M; Matsuura H
Eur J Pharmacol; 2008 Dec; 600(1-3):18-25. PubMed ID: 18930721
[TBL] [Abstract][Full Text] [Related]
20. The sensitivity of the human Kv1.3 (hKv1.3) lymphocyte K+ channel to regulation by PKA and PKC is partially lost in HEK 293 host cells.
Martel J; Dupuis G; Deschênes P; Payet MD
J Membr Biol; 1998 Jan; 161(2):183-96. PubMed ID: 9435274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
